WallachBeth Capital announced the completion of a joint underwritten public offering of 1,200,000 shares for Lixte Biotechnology Holdings, Inc. (NASDAQ: Common stock – LIXT; Warrants – LIXTW) at an offering price of $4.75 per unit for total gross proceeds of $5.7 million. Each unit consists of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $5.70 per share. In addition, Lixte has granted the underwriters a 45-day option to purchase up to 180,000 additional shares of the Company’s common stock and/or up to 180,000 additional warrants to purchase shares of the Company’s common stock, or any combination thereof, to cover overallotments, if any. The shares and warrants began trading on The NASDAQ Capital Market on Wednesday, November 25, 2020, under the symbols “LIXT” and “LIXTW”, respectively.